AP2012006292A0 - Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection. - Google Patents
Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection.Info
- Publication number
- AP2012006292A0 AP2012006292A0 AP2012006292A AP2012006292A AP2012006292A0 AP 2012006292 A0 AP2012006292 A0 AP 2012006292A0 AP 2012006292 A AP2012006292 A AP 2012006292A AP 2012006292 A AP2012006292 A AP 2012006292A AP 2012006292 A0 AP2012006292 A0 AP 2012006292A0
- Authority
- AP
- ARIPO
- Prior art keywords
- hydroxytyrosol
- prevention
- derivatives
- hiv infection
- topical use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382267 | 2009-12-01 | ||
| PCT/EP2010/068673 WO2011067302A1 (en) | 2009-12-01 | 2010-12-01 | Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2012006292A0 true AP2012006292A0 (en) | 2012-06-30 |
Family
ID=43800358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2012006292A AP2012006292A0 (en) | 2009-12-01 | 2010-12-01 | Topical use of hydroxytyrosol and derivatives for the prevention of HIV infection. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120260922A1 (en) |
| EP (1) | EP2506841A1 (en) |
| JP (1) | JP2013512275A (en) |
| KR (1) | KR20120099473A (en) |
| CN (1) | CN102711745A (en) |
| AP (1) | AP2012006292A0 (en) |
| AU (1) | AU2010326618A1 (en) |
| BR (1) | BR112012013252A2 (en) |
| CA (1) | CA2782441A1 (en) |
| MX (1) | MX2012006297A (en) |
| NZ (1) | NZ600912A (en) |
| RU (1) | RU2560879C2 (en) |
| WO (1) | WO2011067302A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
| CN103122025B (en) * | 2011-11-21 | 2017-09-05 | 中国人民解放军军事医学科学院毒物药物研究所 | Small molecule-polypeptide conjugate for inhibiting HIV infection |
| US9144555B2 (en) | 2012-11-30 | 2015-09-29 | Darlene E. McCord | Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition |
| US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
| US9919034B2 (en) | 2014-03-28 | 2018-03-20 | Tamir Biotechnology, Inc. | Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V |
| US9642794B2 (en) * | 2014-08-18 | 2017-05-09 | Tamir Biotechnology, Inc. | Antiviral pharmaceutical for topical administration |
| US20160045574A1 (en) * | 2014-08-18 | 2016-02-18 | Tamir Biotechnology, Inc. | Antiviral pharmaceutical for topical administration |
| US10835598B2 (en) | 2014-08-18 | 2020-11-17 | Orgenesis Inc. | Prophylactic protection against viral infections, particularly HIV |
| WO2016205109A1 (en) | 2015-06-15 | 2016-12-22 | Tamir Biotechnology, Inc. | Pharmaceuticals for treatment of viral infections of the eye |
| CN108676067B (en) * | 2018-03-23 | 2019-09-06 | 广州朗圣药业有限公司 | A novel compound for preventing HIV infection and its preparation method |
| CN109010329A (en) * | 2018-09-29 | 2018-12-18 | 西安交通大学 | Hydroxytyrosol acetate is improving the application in blood vessel endothelium dysfunction disease |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2149240A (en) | 1938-05-19 | 1939-02-28 | Calco Chemical Co Inc | Vaginal preparation |
| US2330846A (en) | 1939-05-01 | 1943-10-05 | Ortho Products Inc | Spermicide |
| US2467884A (en) | 1944-02-02 | 1949-04-19 | Nathaniel M Elias | Spermicides |
| US2436184A (en) | 1945-11-08 | 1948-02-17 | Eaton Lab Inc | Pharmaceutical jelly |
| US2541103A (en) | 1948-04-27 | 1951-02-13 | Ortho Pharma Corp | Spermicidal composition |
| US2623841A (en) | 1950-11-21 | 1952-12-30 | Schmid Inc Julius | Spermicidal compositions |
| US2623839A (en) | 1950-11-21 | 1952-12-30 | Schmid Inc Julius | Spermicidal compositions |
| US3062715A (en) | 1953-11-18 | 1962-11-06 | George S Pfaus | Vaginal tablet |
| US3067743A (en) | 1958-11-12 | 1962-12-11 | Alginate Ind Ltd | Alginic compounds |
| US3108043A (en) | 1960-05-09 | 1963-10-22 | Ortho Pharma Corp | Spermicidal sheet-like material |
| US3174900A (en) | 1962-10-10 | 1965-03-23 | Holland Rantos Company Inc | Thioether spermicidal method and composition |
| US3244589A (en) | 1962-10-26 | 1966-04-05 | Sunnen | Alkyl phenoxy polyethoxy ether spermicidal aerosol |
| US3916898A (en) | 1964-05-20 | 1975-11-04 | Searle & Co | Administration of medicaments and the like |
| US3887699A (en) | 1969-03-24 | 1975-06-03 | Seymour Yolles | Biodegradable polymeric article for dispensing drugs |
| US3640741A (en) | 1970-02-24 | 1972-02-08 | Hollister Inc | Composition containing gel |
| FR2097520A5 (en) | 1970-07-09 | 1972-03-03 | Morel Paul | |
| US3888975A (en) | 1972-12-27 | 1975-06-10 | Alza Corp | Erodible intrauterine device |
| US4017641A (en) | 1975-01-31 | 1977-04-12 | The Procter & Gamble Company | Skin moisturizing compositions containing 2-pyrrolidinone |
| US3989816A (en) | 1975-06-19 | 1976-11-02 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacycloheptan-2-ones |
| US4011312A (en) | 1975-06-25 | 1977-03-08 | American Home Products Corporation | Prolonged release drug form for the treatment of bovine mastitis |
| IT1039699B (en) | 1975-07-03 | 1979-12-10 | Prephar | SPERMICIDE COMPOSITION BASED ON BENZISOTHIAZOLIC DERIVATIVES |
| US4130667A (en) | 1976-01-12 | 1978-12-19 | The Procter & Gamble Company | Dermatological compositions |
| US4108309A (en) | 1976-10-15 | 1978-08-22 | All One God Faith, Inc. | Contraceptive containing device |
| FR2433949A1 (en) | 1978-08-25 | 1980-03-21 | Commissariat Energie Atomique | HYDROPHOBIC SUBSTRATE CAPABLE OF RELEASING A CHEMICAL SUBSTANCE |
| US4321277A (en) | 1978-12-04 | 1982-03-23 | Research Lab Products, Inc. | Germicidal use of compositions containing certain quaternary ammonium compounds |
| US4187286A (en) | 1979-01-02 | 1980-02-05 | G&W Laboratories, Inc. | Contraceptive suppository |
| US4954487A (en) | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
| US4360013A (en) | 1980-04-21 | 1982-11-23 | Minnesota Mining And Manufacturing Company | Polymeric acid contraceptive devices |
| IT1131833B (en) | 1980-06-20 | 1986-06-25 | Crinos Industria Farmaco | EXCIPIENTS FOR SPERMICIDE SUBSTANCES |
| US4389330A (en) | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
| US4368186A (en) | 1981-05-07 | 1983-01-11 | Syntex (U.S.A.) Inc. | Methods and compositions for intravaginal contraception |
| US4415585A (en) | 1982-03-11 | 1983-11-15 | University Of Illinois Foundation | Contraceptive method |
| US5248700A (en) | 1982-05-14 | 1993-09-28 | Akzo Nv | Active agent containing solid structures for prolonged release of active agents |
| US4961931A (en) | 1982-07-29 | 1990-10-09 | Alza Corporation | Method for the management of hyperplasia |
| US4499154A (en) | 1982-09-03 | 1985-02-12 | Howard L. Podell | Dipped rubber article |
| US4551148A (en) | 1982-09-07 | 1985-11-05 | Kv Pharmaceutical Company | Vaginal delivery systems and their methods of preparation and use |
| US4552872A (en) | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
| US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| US4537776A (en) | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
| US4589880A (en) | 1983-07-14 | 1986-05-20 | Southern Research Institute | Disposable spermicide-releasing diaphragm |
| US5231112A (en) | 1984-04-12 | 1993-07-27 | The Liposome Company, Inc. | Compositions containing tris salt of cholesterol hemisuccinate and antifungal |
| US4895724A (en) | 1985-06-07 | 1990-01-23 | Pfizer Inc. | Chitosan compositions for controlled and prolonged release of macromolecules |
| US4795642A (en) | 1986-05-01 | 1989-01-03 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| US5208031A (en) | 1989-06-06 | 1993-05-04 | Kelly Patrick D | Sexual lubricants containing zinc as an anti-viral agent |
| US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
| DE4015543A1 (en) | 1990-05-15 | 1991-11-21 | Bayer Ag | SPERMICIDES COATING AGENT |
| US5143731A (en) | 1990-08-07 | 1992-09-01 | Mediventures Incorporated | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
| FR2666587B1 (en) | 1990-09-10 | 1993-06-25 | Dow Corning Sa | LUBRICANT COMPOSITIONS AND THEIR USE. |
| GB9021061D0 (en) | 1990-09-27 | 1990-11-07 | Unilever Plc | Encapsulating method and products containing encapsulated material |
| GB9507883D0 (en) * | 1995-04-18 | 1995-05-31 | Retroscreen Ltd | Compounds |
| US20020132791A1 (en) * | 2000-03-08 | 2002-09-19 | Hildreth James E. | Beta-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases |
| US7713569B2 (en) * | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| NZ534884A (en) * | 2002-02-13 | 2007-05-31 | Creagri Inc | Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| WO2003082259A1 (en) * | 2002-04-03 | 2003-10-09 | Puleva Biotech, S.A. | Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases |
| JP2004131528A (en) * | 2002-10-08 | 2004-04-30 | Yasushi Okubo | Lubricant pharmaceutical preparation |
| JP3799340B2 (en) * | 2003-07-18 | 2006-07-19 | 一丸ファルコス株式会社 | Hydroxytyrosol, application to topical skin preparation |
| US20090232748A1 (en) * | 2003-11-07 | 2009-09-17 | Viratox, L.L.C. | Virucidal activities of cetylpyridinium chloride |
| US20090163579A1 (en) * | 2005-10-14 | 2009-06-25 | Daniel Raederstorff | Novel use of nutraceutical compositions |
| JP2007182398A (en) * | 2006-01-06 | 2007-07-19 | Nakajima Kagaku Sangyo Kk | Antiviral lubricant |
| ES2286953B1 (en) * | 2006-05-18 | 2008-12-16 | Universidad De Granada | FORMULATION OF NATURAL TRITERPENES AND BIOPHENOLS OBTAINED FROM THE OLEA GENDER IN LIPOSOMAS. |
| US20090061031A1 (en) * | 2006-07-07 | 2009-03-05 | Sylvia Lee-Huang | Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
| WO2008148018A2 (en) * | 2007-05-24 | 2008-12-04 | New York Blood Center Inc. | Rapidly dispersible vaginal tablet that provides a bioadhesive gel |
| CN101342102A (en) * | 2007-07-10 | 2009-01-14 | 赛买提·依明 | Premature ejaculation-preventing condom for helping hand intercourse |
| WO2009109679A1 (en) * | 2008-03-04 | 2009-09-11 | Universidad De Granada | Use of virgin olive oil polyphenolic compounds in cancer treatment |
| CA2769819C (en) * | 2009-08-10 | 2015-07-21 | Darlene Mccord | Nutritional supplements |
-
2010
- 2010-12-01 AP AP2012006292A patent/AP2012006292A0/en unknown
- 2010-12-01 NZ NZ600912A patent/NZ600912A/en not_active IP Right Cessation
- 2010-12-01 EP EP10798526A patent/EP2506841A1/en not_active Withdrawn
- 2010-12-01 AU AU2010326618A patent/AU2010326618A1/en not_active Abandoned
- 2010-12-01 CA CA2782441A patent/CA2782441A1/en not_active Abandoned
- 2010-12-01 US US13/513,061 patent/US20120260922A1/en not_active Abandoned
- 2010-12-01 RU RU2012127436/04A patent/RU2560879C2/en not_active IP Right Cessation
- 2010-12-01 WO PCT/EP2010/068673 patent/WO2011067302A1/en not_active Ceased
- 2010-12-01 BR BR112012013252-0A patent/BR112012013252A2/en not_active IP Right Cessation
- 2010-12-01 JP JP2012541493A patent/JP2013512275A/en active Pending
- 2010-12-01 KR KR1020127016463A patent/KR20120099473A/en not_active Withdrawn
- 2010-12-01 MX MX2012006297A patent/MX2012006297A/en not_active Application Discontinuation
- 2010-12-01 CN CN201080061486XA patent/CN102711745A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120099473A (en) | 2012-09-10 |
| JP2013512275A (en) | 2013-04-11 |
| RU2560879C2 (en) | 2015-08-20 |
| EP2506841A1 (en) | 2012-10-10 |
| AU2010326618A1 (en) | 2012-07-19 |
| BR112012013252A2 (en) | 2018-05-29 |
| NZ600912A (en) | 2014-05-30 |
| MX2012006297A (en) | 2012-07-23 |
| CA2782441A1 (en) | 2011-06-09 |
| RU2012127436A (en) | 2014-01-20 |
| WO2011067302A1 (en) | 2011-06-09 |
| CN102711745A (en) | 2012-10-03 |
| US20120260922A1 (en) | 2012-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2400017I1 (en) | Combinations of dolutegravir and lamivudine for the treatment of hiv infection | |
| HUS2100027I1 (en) | Purified active polypeptides or immunoconjugates | |
| IL216254A (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof | |
| IL215799A (en) | Quinazolone compounds, pharmaceutical compositions comprising the same and uses thereof | |
| IL253038A0 (en) | Compositions and methods for the treatment of the prevention oral infections by e. coli | |
| AP2011005901A0 (en) | Thienopyridine derivatives for the treatment and prevention of dengue virus infections. | |
| MX305105B (en) | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products. | |
| IL219325A0 (en) | Gadd45beta targeting compounds, compositons comprising the same and uses thereof | |
| WO2011077043A3 (en) | Phenol derivatives and pharmaceutical or cosmetic use thereof | |
| HUE048670T2 (en) | Combinations comprising 5-phenoxy-3h-pyrimidin-4-one derivatives and their use for the prophylaxis or treatment of infection by hiv | |
| WO2011057262A3 (en) | Treatment of infections with tp receptor antagonists | |
| IL218490A0 (en) | Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof | |
| PL2584074T3 (en) | Large area deposition and doping of graphene, and products including the same | |
| WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
| PL2739615T3 (en) | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament | |
| BRPI1012155A2 (en) | safety catheter. | |
| IL219888A0 (en) | Pyridine-pyridinone derivatives, preparation and therapeutic use thereof | |
| IL216828A0 (en) | Styryl-triazine derivatives, compositions comprising the same and uses thereof | |
| ZA201107363B (en) | Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof | |
| WO2010148314A3 (en) | Preparation of esomeprazole and its pharmaceutically acceptable salts | |
| IL225724A (en) | Acylbenzene derivatives, compositions comprising the same and uses thereof | |
| PT2488158E (en) | IMPROVED MEDICINAL FORMULATIONS IN THE FORM OF AEROSOL | |
| SI2421864T1 (en) | 1-pyrazološ4,3-cćisoquinoline derivatives, preparation thereof and therapeutic use thereof | |
| ZA201202797B (en) | The use of a herbal composition for the treatment of a person infected with hiv | |
| IL213996A0 (en) | Sulfamoyl-phenyl-ureido-benzamidine derivatives, compositions comprising the same and uses thereof |